Dr. Sung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Duke University
Baltimore, MD 27710- Is this information wrong?
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
- Johns Hopkins UniversityInternship, Internal Medicine, 2008 - 2011
- Harvard Medical SchoolClass of 2008
Certifications & Licensure
- NC State Medical License 2011 - 2024
- American Board of Internal Medicine Hematology
Clinical Trials
- MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2021 Sep 01
- ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients Start of enrollment: 2020 Oct 14
- Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 Start of enrollment: 2014 Sep 03
Roles: Sub-Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEfficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial.Paul E Wischmeyer, Helen Tang, Yi Ren, Lauren Bohannon, Danting Jiang, Matthew Bergens, Zeni E Ramirez, Tessa M Andermann, Julia A Messina, Julia A Sung, David Jensen,...> ;Clinical Nutrition. 2024 Jan 1
- 2 citationsThe use of commercial wrist-worn technology to track physiological outcomes in behavioral interventions.Ashley L Artese, Rahul Rawat, Anthony D Sung> ;Current Opinion in Clinical Nutrition and Metabolic Care. 2023 Nov 1
- 7 citationsHigh-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.Chi L Nguyen, Kate A Markey, Oriana Miltiadous, Anqi Dai, Nicholas Waters, Keimya Sadeghi, Teng Fei, Roni Shouval, Bradford P Taylor, Chen Liao, John B Slingerland, An...> ;Cell. 2023 Jun 8
- Join now to see all
Press Mentions
- More Options for People with Blood CancersMay 10th, 2023
- FDA Panel Says Poziotinib’s Benefits Don’t Outweigh Risks in NSCLC With HER2 Exon 20 MutationsSeptember 22nd, 2022
- FDA Panel Puts PI3K Inhibitors for Blood Cancers on NoticeApril 22nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: